Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Prognostic Immune Markers in Patients With Ovarian Cancer

NCT03862677 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT03862677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03862677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Prognostic Immune Markers in Patients With Ovarian Cancer
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
August 15, 2020
Completion date
January 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer